Give Cancer the Boot – Breast Cancer Awareness Shirt

Give Cancer the Boot – Breast Cancer Awareness Shirt

Marsoni

M251S

$12.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Give Cancer the Boot – Breast Cancer Awareness ShirtKick cancer to the curb in style. The Give Cancer the Boot Breast Cancer Awareness Shirt is bold, empowering, and full of attitude. Designed for fighters, survivors, and supporters, this tee represents the strength to stand tall and stomp out breast cancer with every step. Made from premium, soft spun cotton, this unisex shirt delivers comfort, durability, and a message that means something. The Give Cancer the Boot design features a pink awareness

Easy Shipping

Quick Dispatch:

Your Give Cancer the Boot – Breast Cancer Awareness Shirt orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Give Cancer the Boot – Breast Cancer Awareness Shirt ships.

Need Help?
Questions about Give Cancer the Boot – Breast Cancer Awareness Shirt, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Give Cancer the Boot – Breast Cancer Awareness Shirt in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Cute set but runs a bit big in my opinion for a size 2T. My grandbaby is tall for her age (22 months), but the pants were really long and loose on her, granted she's not chunky, so factor that in. Overall, it's a nice set and the material is soft (especially the pants) and seems like it would keep the little ones warm.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on December 31, 2025